SCHEMBL428612

SCHEMBL428612

Cc1cccc(C=NNc2cc(N3CCOCC3)cc(OCCCC(=O)NC3CCCCC3)n2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.50
LMNA P02545 3/20 0.50
KDM4E B2RXH2 3/20 0.50
HPGD P15428 1/20 0.50
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
PIKFYVE Q9Y2I7 5/20 0.48
FES P07332 1/20 0.48
FER P16591 1/20 0.48
TYK2 P29597 1/20 0.48
FRK P42685 1/20 0.48
SYK P43405 1/20 0.48
CAMK1D Q8IU85 1/20 0.48
IRAK4 Q9NWZ3 1/20 0.48
TSHR P16473 1/20 0.44
ALDH1A1 P00352 1/20 0.43
SENP7 Q9BQF6 1/20 0.43
SENP6 Q9GZR1 1/20 0.43
L3MBTL1 Q9Y468 2/20 0.42
ALOX15 P16050 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL428611 1.00 MAPT (0.50) MAPTLMNAKDM4EHPGDMEN1
SCHEMBL425079 0.89 MAPT (0.50) MAPTLMNAKDM4EHPGDMEN1
SCHEMBL425078 0.89 MAPT (0.50) MAPTLMNAKDM4EHPGDMEN1
SCHEMBL427822 0.87 MAPT (0.52) MAPTLMNAKDM4EHPGDMEN1
SCHEMBL427821 0.87 MAPT (0.52) MAPTLMNAKDM4EHPGDMEN1
SCHEMBL429733 0.86 MAPT (0.52) MAPTLMNAKDM4EHPGDMEN1
SCHEMBL429732 0.86 MAPT (0.52) MAPTLMNAKDM4EHPGDMEN1
SCHEMBL425425 0.85 PIKFYVE (0.51) MAPTLMNAKDM4EHPGDMEN1
SCHEMBL430803 0.85 MAPT (0.51) MAPTLMNAKDM4EHPGDMEN1
SCHEMBL425426 0.85 PIKFYVE (0.51) MAPTLMNAKDM4EHPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1687004-A4 PYRIDINE COMPOUNDS SYNTA PHARMACEUTICALS CORP (US) 2009-04-08 EP claimed
JP-2007510747-A 2007-04-26 JP claimed
EP-1687004-A2 PYRIDINE COMPOUNDS Synta Pharmaceuticals Corporation (US) 2006-08-09 EP claimed
WO-2005046603-A2 PYRIDINE COMPOUNDS SYNTA PHARMACEUTICALS, CORP. (US) 2005-05-26 WO claimed
US-20120021434-A1 METHOD FOR TREATING B CELL REGULATED AUTOIMMUNE DISORDERS SYNTA PHARMACEUTICALS CORP. (US) 2012-01-26 US disclosed